Articles

Benjamin P. Levy, MD, provides an overview of evolving strategies to manage patients with acquired TKI resistance in advanced non–small-cell lung cancer with a focus on identifying and treating t790m.

Utilizing Chemotherapy to Treat Lung Cancer

By Benjamin P. Levy, MD

ASCO, ASCO 2016 – Lung Cancer

Videos

Benjamin P. Levy, MD, talks about the role chemotherapy currently plays in an arena where the cancer care team is emphasizing genomic profiling and targeted therapies to treat patients with lung cancer.

5-Azacitidine plus Checkpoint Inhibitor May Enhance Outcomes in Patients with De Novo and Relapsed AML

EHA 2016 – Leukemia, EHA

Conference Correspondent

Acalabrutinib, a Second-Generation BTK Inhibitor, Is Active in Previously Untreated CLL

EHA 2016, EHA 2016 – Leukemia, EHA

Conference Correspondent

ALL – Clinical Oral Presentations: Saturday, June 11

EHA 2016, EHA 2016 – Leukemia, EHA

Conference Correspondent

ALL – Clinical Poster Session: Friday, June 10

EHA 2016, EHA 2016 – Leukemia, EHA

Conference Correspondent